ASCO Annual Meeting

2024 ASCO Annual Meeting

ODA-ASCO 2024-Arlene Siefker-Radtke, MD_960x800
ODA-ASCO 2024-Daniel Rubin, PharmD_960x800
ODA-ASCO 2024-Andrea Roman, PharmD, BCOP_960x800 (1)
ODA-ASCO 2024-Lakshmi Nayak, MD_960x800
ODA-ASCO 2024-Ahsan Arozullah, MD, MPH_960x800
ODA-ASCO 2024-Rebecca Nellis, MPP_960x800
ODA-ASCO 2024-Mike Scherer_960x800
ODA-ASCO 2024-Shubham Pant, MD_960x800
ODA-ASCO 2024-Ishwaria Subbiah, MD_960x800
1 2 3 5

2023 ASCO Annual Meeting

Dr. Kohei Shitara discusses the efficacy of zolbetuximab for gastric/gastroesophageal junction adenocarcinoma.
A collection of clinician's advice and thoughts regarding this year's ASCO Annual Meeting theme,
Kathleen Moore discusses her presentation regarding the results of the MIRASOL trial of mirvetuximab soravtansine for ovarian cancer.
Dr. Nichoals Phillips discusses accelerated brain age and neurocognitive impairments in childhood cancer survivors.
b2ap3_large_Podcast-Interview-2023-ASCO-Thomas-Hutson-MD-compressed
Dr. Puneeth Indurlal discusses his research regarding dose rounding bevacizumab to reducing drug waste and cost of care.
Dr. Nicholas Robert explains the impacts of social determinants of health in triple-negative breast cancer treatment.
Dr. Michael Halpern discusses effects of employment disruptions and financial hardship experienced by patients with cancer.
Noelle Cloven discusses the ongoing ARTISTRY-7 trial studying nemvaleukin alfa for platinum-resistant ovarian cancers.
1 2 3 4

2022 ASCO Annual Meeting

b2ap3_large_2022-Video-Interview-ASCO-2022-Urvi-Shah-MD-MM_960x800-compressed
In this interview from ASCO, Karen Basen-Engquist discusses behavioral strategies to get your patients with cancer exercising and why it is important.
b2ap3_large_2022-ODA-Expert-Perspectives-Ash-Alpert-MD-MFA_960x800-1-compressed
In this interview, Colin Ferro explains Epic Experiences, a nonprofit based in Colorado that aims to empowers cancer survivors to thrive beyond their diagnosis.
Ian Krop discusses his research and data on the HER3-targeting antibody-drug conjugate patritumab deruxtecan for treatment of breast cancer.
In this interview, Jeannie Tie goes into more detail about her presentation at ASCO regarding ctDNA analysis for treatment of colorectal cancer.
In this interview, Jessica Jones, MD, discusses her work in cancer detection and prevention in Black women with a higher risk for breast cancer.
In this interview, Alexander Spira discusses his presentation about the results of adagrasib as to advancing treatment for non-small cell lung cancer.
Dr. Jason Mouabbi talks about his ASCO poster on survival and treatment outcomes of patients with lobular breast cancer
1 2 3 4